skip to Main Content

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis.

© 2025 AccentBio. All Rights Reserved.
Site designed by Grid24 a division of Grid24 Ltd.

Back To Top